In VC-treated xenografts, a slightly stronger regression of tumor growth was seen in CD44 KD xenografts compared with CD147 KD xenografts, while no obvious difference was found between growth of CD44 KD and CD147 KD tumors (P>0.05). Here, CD44 is linked to neoplasm.